Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 7, 2012, Pages 1121-1129

  Yang, Tian ^a   Lin, Chuan ^a   Zhai, Jian ^a   Shi, Song ^a   Zhu, Min ^a   Zhu, Nan ^a   Lu, Jun Hua ^a   Yang, Guang Shun ^a   Wu, Meng Chao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Long term survival; Morbidity; Mortality; Staging; Surgical resection

Indexed keywords

ABDOMINAL BLEEDING; ADULT; AGED; ARTICLE; BARCELONA CLINIC LIVER CANCER STAGING; CANCER CLASSIFICATION; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PATIENT SAFETY; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; DATABASES, FACTUAL; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84864376162     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1188-0     Document Type: Article

References (39)

1. Aldrighetti L, Pulitano C, Catena M et al (2009) Liver resection with portal vein thrombectomy for hepatocellular carcinoma with vascular invasion. Ann Surg Oncol 16(5):1254
2. Bruix J, Llovet JM (2009) Major achievements in hepatocellular carcinoma. Lancet 373(9664):614-616
3. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5):1208-1236 (Pubitemid 43112690)
4. Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35(3):421-430 (Pubitemid 32844200)
5. Chen MF, Jan YY, Jeng LB, Hwang TL, Wang CS, Chen SC (1994) Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 cases. Cancer 73(5):1335-1340
6. Chen XP, Qiu FZ, Wu ZD et al (2006) EVects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 13(7):940-946
7. Cheng AL, Kang YK, Chen Z et al (2009) EYcacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10(1):25-34
8. Cillo U, Vitale A, Grigoletto F et al (2006) Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 44(4):723-731
9. Esaki M, Shimada K, Sano T, Sakamoto Y, Kosuge T, Ojima H (2005) Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparison between macroscopic and microscopic tumor thrombus. J Surg Oncol 90(4):226-232 (Pubitemid 40770937)
10. Fukuda S, Okuda K, Imamura M, Imamura I, Eriguchi N, Aoyagi S (2002) Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery 131(3):300-310 (Pubitemid 34229783)
11. Grieco A, Pompili M, Caminiti G et al (2005) Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut 54(3):411-418 (Pubitemid 40299100)
12. Ikenaga N, Chijiiwa K, Otani K, Ohuchida J, Uchiyama S, Kondo K (2009) Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg 13(3):492-497
13. Inoue Y, Hasegawa K, Ishizawa T et al (2009) Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma. Surgery 145(1):9-19
14. Kondo K, Chijiiwa K, Kai M et al (2009) Surgical strategy for hepatocellular carcinoma patients with portal vein tumor thrombus based on prognostic factors. J Gastrointest Surg 13(6):1078-1083
15. Konishi M, Ryu M, Kinoshita T, Inoue K (2001) Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 48(41):1421-1424 (Pubitemid 33010438)
16. Lau WY, Lai EC (2007) Salvage surgery following downstaging of unresectable hepatocellular carcinoma - A strategy to increase resectability. Ann Surg Oncol 14(12):3301-3309 (Pubitemid 350160117)
17. Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7(3):237-257 (Pubitemid 351895383)
18. Lau WY, Leung TW, Leung KL et al (1994) Cytoreductive surgery for hepatocellular carcinoma. Surg Oncol 3(3):161-166 (Pubitemid 24269834)
19. Lau WY, Leung KL, Leung TW, Liew CT, Chan M, Li AK (1995) Resection of hepatocellular carcinoma with diaphragmatic invasion. Br J Surg 82(2):264-266
20. Lau WY, Lai EC, Leung TW, Yu SC (2008) Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival. Ann Surg 247(1):43-48
21. Le TYP, Hardwigsen J, Ananian P et al (2006) Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointest Surg 10(6):855-862 (Pubitemid 43850379)
22. Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48(4):1312-1327
23. Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19(3):329-338
24. Llovet JM, Di BAM, Bruix J et al (2008a) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100(10):698-711
25. Llovet JM, Ricci S, Mazzaferro V et al (2008b) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359(4):378-390
26. Marrero JA (2006) Staging systems for hepatocellular carcinoma: should we all use the BCLC system. J Hepatol 44(4):630-632
27. Marrero JA, Fontana RJ, Barrat A et al (2005) Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology 41(4):707-716 (Pubitemid 40462931)
28. Matsuda M, Suzuki T, Kono H, Fujii H (2007) Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins. J Hepatobiliary Pancreat Surg 14(3):289-296 (Pubitemid 46863919)
29. Minagawa M, Makuuchi M, Takayama T, Ohtomo K (2001) Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 233(3):379-384 (Pubitemid 32187817)
30. Pawlik TM, Poon RT, Abdalla EK et al (2005) Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137(4):403-410 (Pubitemid 40432037)
31. Peng SY, Wang JW, Liu YB et al (2004a) Hepatocellular carcinoma with bile duct thrombi: analysis of surgical treatment. Hepatogastroenterology 51(57):801-804
32. Peng SY, Wang JW, Liu YB et al (2004b) Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma. World J Surg 28(1):43-46 (Pubitemid 38095791)
33. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60(8):646-649
34. Qin LX, Tang ZY (2003) Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol 9(3):385-391
35. Thomas MB, Zhu AX (2005) Hepatocellular carcinoma: the need for progress. J Clin Oncol 23(13):2892-2899 (Pubitemid 46224106)
36. Wu MC (2004) Operative treatment of tumor thrombus in the portal vein. Zhonghua Yi Xue Za Zhi 84(1):1-2
37. Xiangji L, Weifeng T, Bin Y et al (2009) Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities. Langenbecks Arch Surg 394(6):1033-1039
38. Yang T, Zhang J, Lu JH et al (2011) A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 137(5):739-750
39. Yeh CN, Jan YY, Lee WC, Chen MF (2004) Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg 28(5):471-475